Abstract Submission
NEW ABSTRACT SUBMISSION DEADLINE: DECEMBER 15, 2021
Late breaker deadline : on request – strict conditions to be complied with.
All abstracts must be submitted through the online abstract submission system.
Abstract topics
For review purposes, abstracts are classified according to the following list.
Select only 1 topic on our submission form:
- HPV disease and COVID-19
- Viral and molecular biology
- Epidemiology and natural history
- Pathogenesis
- Immunology
- HPV prophylactic vaccines
- HPV therapeutic vaccines
- Immunotherapy - Immuno-oncology - New treatments
- HPV testing
- HPV screening
- Screening for women difficult to reach
- Triage of HPV positive women
- Self-sampling
- Genotyping
- Molecular markers
- Screening methods
- Automation in cytology
- Methylation
- Microbiome
- Serology
- New technologies
- Artificial Intelligence
- Diagnostic procedures / management
- Risk management
- Colposcopy
- Cervical neoplasia
- Vulvar and vaginal diseases and neoplasia
- Anal neoplasia
- Oral HPV infection
- HPV and oropharynx / Head and neck cancer
- HPV and associated skin diseases
- Genital warts
- HPV transmission
- Sexually transmitted diseases and HIV infection
- Conventional therapies
- Economics and modelling
- Advocacy, acceptability and psychology
- Health education
- Low resource settings
- Public health
- Fertility and HPV
EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.
EUROVIR, owning the trademark EUROGIN, is a Trusted Partner of Ethical MedTech.